Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis (BRONCHIOL-EAT)

December 8, 2022 updated by: Yann Combret, Groupe Hospitalier du Havre

Slow Expiratory Technique Efficacy on 24 Hours Food Ingestion in Children Under Than 12 Months, Hospitalized for Bronchiolitis : a Randomized Controlled Study

The purpose of this study is to determine wether a single chest physiotherapy session with slow expiratory technique (SET) improves infants with viral bronchiolitis quality of life (food intake and sleep) on the next 24 hours.

Study Overview

Detailed Description

Bronchiolitis is the most common lower respiratory viral infection in infants. Nowadays bronchiolitis is the first reason of children hospitalisation worldwide. Symptoms are based on airway inflammation associated to an increased mucus production and cell necrosis leading to a multifactorial airway obstruction. Recommended treatments are supportive care based on oxygenation and rehydration. Airway clearance techniques represented by chest physiotherapy remain controversial.

Considering that bronchiolitis impacts respiratory condition in young infants feeding and sleep may be reduced. Evaluating quality of life represented by feeding and sleep in hospitalized infants may be an important outcome in this population.

The investigators hypothesized that chest physiotherapy with SET will improve children's quality of life, especially 24 hours food intake and sleep.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Le Havre, France, 76290
        • Groupe Hospitalier Du Havre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children under 12 months
  • hospitalized for bronchiolitis
  • chest physiotherapy prescription
  • bronchial obstruction confirmed by physician and respiratory physiotherapist

Non-inclusion Criteria :

  • children more than 1 year
  • exclusive breastfeeding or enteral feeding
  • prematurity (gestational age < 35 weeks)
  • cardiac, neurological and pulmonary comorbidity
  • continuous oxygen supplementation or ventilatory support
  • chest physiotherapy contraindications

Exclusion Criteria:

  • side effects during chest physiotherapy : bradycardia <100 bpm, oxygen saturation<90%, general state alteration
  • outing, oxygen supplementation or parenteral nutrition less than 24 hours after randomization
  • chest physiotherapy cessation according to family request

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Chest physiotherapy with SET
Chest physiotherapy will be provided by a single physiotherapist not involved in outcomes assessment. Airway clearance technique will be Slow Expiratory Technique (SET). SET is a slow modulation of airflow in order to remove bronchial secretions within infants lungs. Experimental group will also benefit for standard medical and non-pharmacological care (e.g Standard Treatment)
Chest physiotherapy with SET, and standard treatment (medical treatment, health education, nasopharyngeal clearance, advice)
Standard pharmacological and non-pharmacological treatments (medical treatment, health education, rhinopharyngeal clearance, advices)
Active Comparator: Standard treatment
Medical treatment, health education for parents, rhinopharyngeal clearance using isotonic saline solution, advices.
Standard pharmacological and non-pharmacological treatments (medical treatment, health education, rhinopharyngeal clearance, advices)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food ingestion
Time Frame: 24 hours following intervention
Total Food ingestion within 24 hours after intervention measured by nurses or parents
24 hours following intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality
Time Frame: 24 hours following intervention
Total Sleep Time
24 hours following intervention
Sleep quality
Time Frame: 24 hours following intervention
Desaturation<90% (Pulse oximetry monitoring during sleep) count during diurnal and nocturnal sleep
24 hours following intervention
Oxygen saturation
Time Frame: Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Pulse oximetry monitoring
Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Respiratory rate
Time Frame: Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Pulse oximetry monitoring
Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Heart Rate
Time Frame: Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Pulse oximetry monitoring
Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Respiratory Distress
Time Frame: Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention
Bronchiolitis Severity Score (described by Gajdos et al. as mentioned in the references). The Bronchiolitis Severity Score involves the calculation and addition of three subscores (age-based respiratory rate scale, score of 1-3; retractions, and wheeze scales, both running from 0 to 3). Total score ranges from 1 to 9, with higher scores indicating greater respiratory distress.
Before intervention ; 5 minutes, 30 minutes and 24 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pascal Le Roux, MD, Groupe Hospitalier Du Havre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2019

Primary Completion (Actual)

December 8, 2022

Study Completion (Actual)

December 8, 2022

Study Registration Dates

First Submitted

November 8, 2018

First Submitted That Met QC Criteria

November 8, 2018

First Posted (Actual)

November 13, 2018

Study Record Updates

Last Update Posted (Estimate)

December 9, 2022

Last Update Submitted That Met QC Criteria

December 8, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Viral Bronchiolitis

Clinical Trials on Chest physiotherapy with SET

3
Subscribe